AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26348685 — intervention group
Group type: EXPERIMENTAL
Intervention: Web group
Number of subjects: 235
Study 26348685 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 235
Study 26348685 — intervention group
Group type: COMPARATOR
Intervention: Phone group
Number of subjects: 235
Study 26348685 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapses, fecal incontinence, and laxative use
Number of subjects: 235
Study 24525654 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (200 mg/d)
Number of subjects: 99
Study 24525654 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 99
Study 24525654 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline plus Gabapentin (SERT + GBP)
Number of subjects: 99
Study 24525654 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 99
Study 22068016 — intervention group
Group type: EXPERIMENTAL
Intervention: Strawberry powder (equivalent to four servings of frozen strawberries)
Number of subjects: 20
Study 22068016 — intervention group
Group type: COMPARATOR
Intervention: Control (strawberry-flavoured intervention)
Number of subjects: 20
Study 20018493 — intervention group
Group type: EXPERIMENTAL
Intervention: 50mg/d LY686017
Number of subjects: 189
Study 20018493 — intervention group
Group type: EXPERIMENTAL
Intervention: 20mg/d paroxetine
Number of subjects: 189
Study 20018493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study 18544577 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrification
Number of subjects: 466
Study 18544577 — intervention group
Group type: COMPARATOR
Intervention: Slow freezing
Number of subjects: 466
Study 15922814 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 2696
Study 15922814 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 2696
Study 15922814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2696
Study 15922814 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg and 100 mg
Number of subjects: 2696
Study 15643749 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum
Number of subjects: 173
Study 15643749 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine/xylitol chewing gum
Number of subjects: 173
Study 15643749 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride chewing gum
Number of subjects: 173
Study 15643749 — intervention group
Group type: COMPARATOR
Intervention: Reference group (no intervention)
Number of subjects: 173
Study 10626291 — intervention group
Group type: EXPERIMENTAL
Intervention: LH-RH agonist leuprorelin
Number of subjects: 0
Study 10626291 — intervention group
Group type: COMPARATOR
Intervention: Cytotoxic agent treosulfane
Number of subjects: 0
Study 10626291 — intervention group
Group type: COMPARATOR
Intervention: LH-RH agonists in conventional doses
Number of subjects: 0
Study 8848781 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored dietary information and instruction by a clinical nutritionist
Number of subjects: 49
Study 8848781 — intervention group
Group type: COMPARATOR
Intervention: Regular dietary information from a nurse
Number of subjects: 49
Study 8848781 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dietary information (in-patients)
Number of subjects: 49
Study 8848781 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-patients
Number of subjects: 49
Study 1298616 — intervention group
Group type: EXPERIMENTAL
Intervention: Anal dilatation
Number of subjects: 78
Study 1298616 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior internal sphincterotomy
Number of subjects: 78
Study 1298616 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral sphincterotomy
Number of subjects: 78
Study 6232015 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.0 x 10(6) units of procaine penicillin plus 1 g of probenecid
Number of subjects: 460
Study 6232015 — intervention group
Group type: COMPARATOR
Intervention: 2 g of spectinomycin
Number of subjects: 460
Study 6232015 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin treatment
Number of subjects: 460
Study 6232015 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectinomycin treatment
Number of subjects: 460
Study 6232015 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline (as second-line treatment)
Number of subjects: 460
Study 31622397 — intervention group
Group type: EXPERIMENTAL
Intervention: ASPIRE (smoking prevention interactive experience)
Number of subjects: 110
Study 28086813 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of an opinion leader for CVRM
Number of subjects: 180
Study 28086813 — intervention group
Group type: EXPERIMENTAL
Intervention: Low homophily on positive attitudes for SBP targets
Number of subjects: 180
Study 28086813 — intervention group
Group type: EXPERIMENTAL
Intervention: Low homophily on positive attitudes for LDL targets
Number of subjects: 180
Study 28086813 — intervention group
Group type: EXPERIMENTAL
Intervention: Low homophily on positive attitudes for SBP targets in specific information networks
Number of subjects: 180
Study 28086813 — intervention group
Group type: EXPERIMENTAL
Intervention: Low homophily on positive attitudes for LDL targets in specific information networks
Number of subjects: 180
Study 25939115 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (AA) insomnia regimen
Number of subjects: 30
Study 25939115 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 23097326 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral foot wedging (prescribed laterally wedged foot orthoses)
Number of subjects: 38
Study 23097326 — intervention group
Group type: COMPARATOR
Intervention: Neutral orthoses (control group)
Number of subjects: 38
Study 22048225 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaporized cannabis inhalation (3 times a day on days 2-4 and in the morning of day 5)
Number of subjects: 21
Study 22048225 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release morphine or oxycodone (control group)
Number of subjects: 21
Study 19567545 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic CPB (35‐37 degrees C)
Number of subjects: 50
Study 19567545 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic CPB (28‐30 degrees C)
Number of subjects: 50
Study 16485224 — intervention group
Group type: EXPERIMENTAL
Intervention: Blepharochalasis operation for cosmetic reasons (group 1)
Number of subjects: 32
Study 16485224 — intervention group
Group type: COMPARATOR
Intervention: Blepharochalasis operation for medical reasons (group 2)
Number of subjects: 32
Study 16485224 — intervention group
Group type: EXPERIMENTAL
Intervention: Tear secretion measurement by Schirmer's test and break-up time
Number of subjects: 32
Study 15259908 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2
Number of subjects: 12
Study 15259908 — intervention group
Group type: COMPARATOR
Intervention: HAART alone
Number of subjects: 12
Study 11677339 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic bipolar coagulation of uterine vessels with LUNA (group A)
Number of subjects: 85
Study 11677339 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic bipolar coagulation of uterine vessels only (group B)
Number of subjects: 85
Study 10216646 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 99
Study 10216646 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 99
Study 7875191 — intervention group
Group type: COMPARATOR
Intervention: ramipril + placebo (R+P)
Number of subjects: 22
Study 7875191 — intervention group
Group type: EXPERIMENTAL
Intervention: ramipril + simvastatin (R+S)
Number of subjects: 22
Study 3313202 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg
Number of subjects: 0
Study 3313202 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 100 mg
Number of subjects: 0
Study 3313202 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipipanone 8 mg
Number of subjects: 0
Study 3313202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3313202 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (both doses)
Number of subjects: 0
Study 29921255 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive intervention (coaching sessions by occupational health physicians using motivational interviewing)
Number of subjects: 491
Study 29921255 — intervention group
Group type: COMPARATOR
Intervention: Limited intervention (web-based Health Risk Assessment with advice)
Number of subjects: 491
Study 29921255 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (Extensive and Limited)
Number of subjects: 491
Study 29921255 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive intervention
Number of subjects: 491
Study 29921255 — intervention group
Group type: COMPARATOR
Intervention: Limited intervention
Number of subjects: 491
Study 27621602 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate pedometer use with goal setting
Number of subjects: 130
Study 27621602 — intervention group
Group type: COMPARATOR
Intervention: Delayed pedometer use
Number of subjects: 130
Study 25765670 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 104
Study 24204003 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium intake
Number of subjects: 20
Study 21817806 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy (IT) aiming for BP < 120/80 mm Hg and LDL-C < 80 mg/dl
Number of subjects: 498
Study 21817806 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (CT) aiming for BP < 140/90 mm Hg and LDL-C < 100 mg/dl
Number of subjects: 498
Study 19702078 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu Injection (SFI)
Number of subjects: 60
Study 19702078 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 60
Study 17229605 — intervention group
Group type: EXPERIMENTAL
Intervention: Emedastine difumarate (2 mg b.i.d.)
Number of subjects: 192
Study 17229605 — intervention group
Group type: COMPARATOR
Intervention: Loratadine (10 mg o.d.)
Number of subjects: 192
Study 12843002 — intervention group
Group type: COMPARATOR
Intervention: Mercaptopurine (MP)
Number of subjects: 521
Study 12843002 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioguanine (TG)
Number of subjects: 521
Study 10934673 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-11 (25 micrograms/kg s.c. once daily)
Number of subjects: 18
Study 10934673 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-11 + Maxzide-25 (25 micrograms/kg s.c. once daily + Maxzide-25 twice daily)
Number of subjects: 18
Study 10934673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 9113841 — intervention group
Group type: EXPERIMENTAL
Intervention: Community based childhood injury prevention program providing education and safety supplies
Number of subjects: 0
Study 9113841 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and promotion of proper use of child restraint systems in automobiles
Number of subjects: 0
Study 7902092 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfasalazine (SSZ)
Number of subjects: 80
Study 7902092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 2883132 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocabastine
Number of subjects: 23
Study 2883132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 29503129 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 636
Study 29503129 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemoradiotherapy
Number of subjects: 636
Study 29503129 — intervention group
Group type: EXPERIMENTAL
Intervention: Failure to complete preoperative chemotherapy
Number of subjects: 636
Study 29503129 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenectomy
Number of subjects: 636
Study 29503129 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 636
Study 29503129 — intervention group
Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 636
Study 29503129 — intervention group
Group type: EXPERIMENTAL
Intervention: Oesophago‐cardia resection
Number of subjects: 636
Study 27562409 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung-protective ventilation with tidal volume 6 ml/kg and PEEP 5 cmH2O (group L)
Number of subjects: 66
Study 27562409 — intervention group
Group type: COMPARATOR
Intervention: Standard ventilation with tidal volume 10 ml/kg and PEEP 0 cmH2O (group S)
Number of subjects: 66
Study 25287779 — intervention group
Group type: EXPERIMENTAL
Intervention: GAME intervention (goal-oriented motor training and enrichment intervention programme)
Number of subjects: 30
Study 25287779 — intervention group
Group type: EXPERIMENTAL
Intervention: GAME intervention
Number of subjects: 30
Study 25287779 — intervention group
Group type: COMPARATOR
Intervention: Standard community based care (control)
Number of subjects: 30
Study 22920402 — intervention group
Group type: EXPERIMENTAL
Intervention: Cylindrical abdominoperineal resection (APR)
Number of subjects: 67
Study 21215201 — intervention group
Group type: EXPERIMENTAL
Intervention: Gasless endoscopic thyroidectomy
Number of subjects: 47
Study 21215201 — intervention group
Group type: COMPARATOR
Intervention: Conventional thyroidectomy
Number of subjects: 47
Study 18272140 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment for 4 weeks
Number of subjects: 51
Study 18272140 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 51
Study 16517559 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone treatment (20 microg/kg per day) for 5 days before gonadotrophin treatment
Number of subjects: 25
Study 12918077 — intervention group
Group type: EXPERIMENTAL
Intervention: Current oral contraceptive use
Number of subjects: 10514
Study 12918077 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive use
Number of subjects: 10514
Study 11139006 — intervention group
Group type: EXPERIMENTAL
Intervention: Stressed group (prepared a 4-minute speech)
Number of subjects: 68
Study 11139006 — intervention group
Group type: COMPARATOR
Intervention: Control group (listened to a passage of neutral text)
Number of subjects: 68
Study 9105223 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 13
Study 9105223 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 13
Study 8248274 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil as adjunctive therapy
Number of subjects: 23
Study 8248274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 2863492 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous IgG
Number of subjects: 108
Study 2863492 — intervention group
Group type: COMPARATOR
Intervention: Oral corticosteroids
Number of subjects: 108
Study 31109356 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamponade dressings
Number of subjects: 0
Study 31109356 — intervention group
Group type: COMPARATOR
Intervention: No tamponade
Number of subjects: 0
Study 28495197 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol 10 mg/kg PO BID for 180 days
Number of subjects: 69
Study 28495197 — intervention group
Group type: EXPERIMENTAL
Intervention: AHCC 17 mg/kg plus nucleotides 32 mg/kg PO SID for 180 days
Number of subjects: 69
Study 28495197 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (Allopurinol and Supplement)
Number of subjects: 69
Study 25401419 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 21
Study 25401419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 23613362 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered educational intervention (decision-aid video with or without brief counseling)
Number of subjects: 639
Study 23613362 — intervention group
Group type: EXPERIMENTAL
Intervention: Any intervention (decision-aid video with or without brief counseling)
Number of subjects: 639
Study 21713735 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoanalgesia
Number of subjects: 60
Study 21713735 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 19027357 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal TDCS
Number of subjects: 21
Study 19027357 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal TDCS
Number of subjects: 21
Study 19027357 — intervention group
Group type: COMPARATOR
Intervention: Sham TDCS
Number of subjects: 21
Study 16436132 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha) combined with ribavirin and interleukin-2 (IL-2)
Number of subjects: 20
Study 16436132 — intervention group
Group type: COMPARATOR
Intervention: Interferon-alpha (IFN-alpha) combined with ribavirin
Number of subjects: 20
Study 15070596 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreduction and HIPEC
Number of subjects: 106
Study 15070596 — intervention group
Group type: EXPERIMENTAL
Intervention: Second surgical debulking for recurrent disease
Number of subjects: 106
Study 15070596 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy for recurrent disease
Number of subjects: 106
Study 15070596 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy for recurrent disease
Number of subjects: 106
Study 15070596 — intervention group
Group type: EXPERIMENTAL
Intervention: No further treatment
Number of subjects: 106
Study 10907210 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 24
Study 10907210 — intervention group
Group type: COMPARATOR
Intervention: Relaxation therapy
Number of subjects: 24
Study 9310511 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 130
Study 9310511 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) with HF-OPT
Number of subjects: 130
Study 9310511 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 130
Study 7871050 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 and 0.5 mg/70 kg)
Number of subjects: 0
Study 7871050 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam (60 mg/70 kg)
Number of subjects: 0
Study 7871050 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.5 mg/70 kg)
Number of subjects: 0
Study 2936877 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 31
Study 2936877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 30690879 — intervention group
Group type: COMPARATOR
Intervention: Dietary polyphenols and methylxanthines (pomegranate, orange, lemon, olive, cocoa, and grapeseed extracts plus resveratrol) consumed as three capsules daily for 6 ± 2 days, providing 473.7 mg of phenolics and 19.7 mg of theobromine and caffeine.
Number of subjects: 19
Study 30690879 — intervention group
Group type: COMPARATOR
Intervention: Control group (8 patients) did not consume extracts.
Number of subjects: 19
Study 29187901 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line platinum-based doublet chemotherapy
Number of subjects: 52
Study 25450208 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir 400mg and weight-based ribavirin for 12 weeks
Number of subjects: 60
Study 25450208 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir 400mg and weight-based ribavirin for 24 weeks
Number of subjects: 60
Study 23177415 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin supplementation in culture medium
Number of subjects: 0
Study 23177415 — intervention group
Group type: COMPARATOR
Intervention: Non-supplemented control group
Number of subjects: 0
Study 21860990 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 42
Study 21860990 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention control group
Number of subjects: 42
Study 19224814 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% lidocaine pump spray (Xylocaine pump spray, XPS)
Number of subjects: 31
Study 19224814 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo pump spray
Number of subjects: 31
Study 17035563 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone care management program (3 sessions)
Number of subjects: 207
Study 17035563 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 207
Study 12488372 — intervention group
Group type: EXPERIMENTAL
Intervention: COPA without fentanyl pretreatment
Number of subjects: 75
Study 12488372 — intervention group
Group type: COMPARATOR
Intervention: LMA without fentanyl pretreatment
Number of subjects: 75
Study 12488372 — intervention group
Group type: EXPERIMENTAL
Intervention: COPA with fentanyl pretreatment
Number of subjects: 75
Study 12488372 — intervention group
Group type: COMPARATOR
Intervention: LMA with fentanyl pretreatment
Number of subjects: 75
Study 12488372 — intervention group
Group type: COMPARATOR
Intervention: Placebo group with both devices
Number of subjects: 75
Study 12488372 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices (COPA and LMA)
Number of subjects: 75
Study 11114680 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis in lactose-hydrolysed low-fat milk (LFM)
Number of subjects: 50
Study 11114680 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis in low-fat milk (LFM)
Number of subjects: 50
Study 11114680 — intervention group
Group type: COMPARATOR
Intervention: Reconstituted low-fat milk (LFM)
Number of subjects: 50
Study 8895037 — intervention group
Group type: EXPERIMENTAL
Intervention: Blackcurrant seed oil (BSO) 6 g daily for 8 weeks
Number of subjects: 27
Study 8895037 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil 6 g daily for 8 weeks
Number of subjects: 27
Study 1803595 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate aerosol
Number of subjects: 39
Study 1803595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 6643842 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise fluctuation achieved by modulating a wide band of noise (experiment 1)
Number of subjects: 0
Study 6643842 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrowing the noise bandwidth (experiment 2)
Number of subjects: 0
Study 30610026 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal hypothermia during open partial nephrectomy
Number of subjects: 0